Ubs Group Ag Diffusion Pharmaceuticals Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$3.34 - $4.7 $1,369 - $1,927	-410 Reduced 87.23%	60 $0
Q1 2023 May 12, 2023	BUY	$4.15 - $6.6 $610 - $970	147 Added 45.51%	470 $1,000
Q4 2022 Feb 08, 2023	SELL	$4.64 - $6.52 $2,473 - $3,475	-533 Reduced 62.27%	323 $1,000
Q3 2022 Nov 10, 2022	BUY	$5.35 - $8.38 $2,279 - $3,569	426 Added 99.07%	856 $5,000
Q2 2022 Aug 10, 2022	BUY	$5.66 - $14.0 $2,433 - $6,020	430 New	430 $3,000

Ticker DFFN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,039,120
Market Cap $18.9M
Description
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 a...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.